Allena Pharmaceuticals Inc
ALNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-5,829,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.03 |
| Beta | 1.15 |
| Outstanding Shares | 100,623,730 |
Return
| Return on Equity | -738.41% |
|---|---|
| Return on Assets | -155.10% |
| Return on Invested Capital | -366.86% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0.19 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.22 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.13 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Allena Pharmaceuticals Inc
CEO: Louis Brenner